He Junli bought 6,725 shares of Harvard Apparatus Regenerative Technology, Inc. at $2.15 for $14.5k on Sep 15, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
CEO
CEO
Filed Sep 25, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$14,458.75Shares × reported price
Shares traded
6,725Common Stock
Price per share
$2.15Reported price. Read footnotes for ranges.
% of reported position traded
0.51%This security and ownership context
Holdings after
1,332,930Direct
Trade date
Sep 15, 2026Buy
Filed
Sep 25, 2026, 10:51 AM ET10-day reporting delay
Accession
0001437749-26-031181Code P · Transaction 229597
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 1,326,205 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 11, 2026Conversion683,725$1.05$717,911.25Trade 229595
Sep 11, 2026Buy361,905$1.05$380,000.25Trade 229596
Sep 11, 2026Conversion310,000——Trade 229598
Sep 11, 2026Conversion205,378——Trade 229599
Sep 11, 2026Conversion202,533——Trade 229600
6 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 10 calendar days after the transaction date.

HRGN price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
HRGN · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Oct 2, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Footnotes in full

F1: On September 11, 2026, the Issuer entered into Securities Purchase Agreements with certain investors pursuant to which the investors purchased in a private placement an aggregate of 2,703,727 shares of common stock at a purchase price of $1.05 per share (the "Private Placement"), which closed on September 11, 2026. Included in the Private Placement, the Reporting Person acquired 683,725 shares of common stock in exchange for the conversion and cancellation of an aggregate of $717,911 of outstanding principal and accrued interest under bridge promissory notes previously issued by the Issuer to the Reporting Person on April 14, 2026, May 13, 2026 and July 16, 2026, pursuant to a Securities Purchase Agreement, dated as of September 11, 2026, between the Issuer and the Reporting Person. The shares issued to the Reporting Person were issued at the same $1.05 per share purchase price, and the notes were cancelled in full upon the closing. F2: On September 11, 2026, the Reporting Person also purchased 361,905 shares of common stock of the Issuer in the Private Placement for an aggregate cash purchase price of $380,000, or $1.05 per share, pursuant to a Securities Purchase Agreement, dated as of September 11, 2026, between the Issuer and the Reporting Person, on the same terms as the other investors in the Private Placement. F3: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions from September 15, 2026 to September 23, 2026. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. F4: Each bridge note provided that, upon a qualified equity financing of the Issuer, the Reporting Person could elect to convert the full balance of the note (principal and accrued interest) into the equity securities sold in such financing at the per-unit price paid by the purchasers in the financing. Because the conversion price was not fixed until the closing of the Private Placement, the notes were not derivative securities prior to that date pursuant to Rule 16a-1(c)(6). The conversion price became fixed at $1.05 per share upon the closing of the Private Placement on September 11, 2026, and the Reporting Person converted the full balance of each note on that date. F5: Represents the outstanding principal and accrued interest on the note as of September 11, 2026. F6: The notes were convertible upon the closing of a qualified equity financing and were scheduled to mature on the earlier of the closing of the Issuer's next capital raise with gross proceeds of at least $5,000,000 or the first anniversary of the note's issue date.